Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.

Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK; PRECISE Study Group..

Neuro Oncol. 2010 Aug;12(8):871-81. doi: 10.1093/neuonc/nop054. Epub 2010 Feb 4.

2.

The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis.

Xing WK, Shao C, Qi ZY, Yang C, Wang Z.

Drug Des Devel Ther. 2015 Jun 29;9:3341-8. doi: 10.2147/DDDT.S85943. eCollection 2015 Jun 29. Review.

3.

Cintredekin besudotox in treatment of malignant glioma.

Mut M, Sherman JH, Shaffrey ME, Schiff D.

Expert Opin Biol Ther. 2008 Jun;8(6):805-12. doi: 10.1517/14712598.8.6.805 . Review.

PMID:
18476792
4.

The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.

Shimamura T, Husain SR, Puri RK.

Neurosurg Focus. 2006 Apr 15;20(4):E11. Review.

PMID:
16709016
5.

The role of Gliadel wafers in the treatment of high-grade gliomas.

Bregy A, Shah AH, Diaz MV, Pierce HE, Ames PL, Diaz D, Komotar RJ.

Expert Rev Anticancer Ther. 2013 Dec;13(12):1453-61. doi: 10.1586/14737140.2013.840090. Review.

PMID:
24236823
6.

Chemotherapy wafers for high grade glioma.

Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007294. doi: 10.1002/14651858.CD007294.pub2. Review.

PMID:
21412902
7.

A comprehensive outlook on intracerebral therapy of malignant gliomas.

Buonerba C, Di Lorenzo G, Marinelli A, Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S, Sampson JH.

Crit Rev Oncol Hematol. 2011 Oct;80(1):54-68. doi: 10.1016/j.critrevonc.2010.09.001. Epub 2010 Oct 2. Review.

PMID:
20888252
8.

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.

Husain SR, Puri RK.

J Neurooncol. 2003 Oct;65(1):37-48. Review.

PMID:
14649884
9.

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.

Kioi M, Husain SR, Croteau D, Kunwar S, Puri RK.

Technol Cancer Res Treat. 2006 Jun;5(3):239-50. Review.

PMID:
16700620
10.

The sequential use of carmustine wafers (GliadelĀ®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.

Dixit S, Hingorani M, Achawal S, Scott I.

Br J Neurosurg. 2011 Aug;25(4):459-69. doi: 10.3109/02688697.2010.550342. Epub 2011 Feb 23. Review.

PMID:
21344976
11.

[What type of adjuvant chemotherapy should be proposed for the initial treatment of glioblastoma?].

Ducray F, Honnorat J.

Presse Med. 2007 Sep;36(9 Pt 2):1249-54. Epub 2007 Mar 12. Review. French.

PMID:
17350791
12.

Efficacy and safety of carmustine wafers in the treatment of glioblastoma multiforme: a systematic review.

Zhang YD, Dai RY, Chen Z, Zhang YH, He XZ, Zhou J.

Turk Neurosurg. 2014;24(5):639-45. doi: 10.5137/1019-5149.JTN.8878-13.1. Review.

13.

Convection-enhanced delivery for the treatment of glioblastoma.

Vogelbaum MA, Aghi MK.

Neuro Oncol. 2015 Mar;17 Suppl 2:ii3-ii8. doi: 10.1093/neuonc/nou354. Review.

14.

[Local antitumor treatments].

Menei P, Metellus P.

Neurochirurgie. 2010 Dec;56(6):483-5. doi: 10.1016/j.neuchi.2010.07.012. Epub 2010 Sep 24. Review. French.

PMID:
20869735
15.

Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas.

Olivi A, Brem H.

Recent Results Cancer Res. 1994;135:149-54. Review. No abstract available.

PMID:
8047689
16.

Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.

Ung TH, Malone H, Canoll P, Bruce JN.

CNS Oncol. 2015;4(4):225-34. doi: 10.2217/cns.15.12. Epub 2015 Jun 24. Review.

PMID:
26103989
17.

Current medical treatment of glioblastoma.

Venur VA, Peereboom DM, Ahluwalia MS.

Cancer Treat Res. 2015;163:103-15. doi: 10.1007/978-3-319-12048-5_7. Review.

PMID:
25468228
18.

Imaging of convection enhanced delivery of toxins in humans.

Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH.

Toxins (Basel). 2011 Mar;3(3):201-6. doi: 10.3390/toxins3030201. Epub 2011 Mar 15. Review.

19.

Convection-enhanced delivery for the treatment of brain tumors.

Debinski W, Tatter SB.

Expert Rev Neurother. 2009 Oct;9(10):1519-27. doi: 10.1586/ern.09.99. Review.

Supplemental Content

Support Center